Chief Scientific Adviser to the Government of India Dr. K. Vijay Raghavan has said that the process of making vaccines in the country for Covid-19 is in full swing and by October some companies may be able to reach its pre-clinical studies. He said that there are four procedures for making vaccines worldwide. All four of these methods are being used in India to make vaccines for Covid-19.
Dr. Raghavan said, ‘Some companies are doing R&D in the backbone of a flu vaccine, it seems that pre-clinical studies will be done by October. Some are in the process of making proteins by February 2021 and making vaccines. Some startups and some academics are also preparing to make the vaccine. We are also partnering with foreign companies. He said that we are leading in partnership with some foreign companies while we are led by some.
It will be 10 times the cost to make a vaccine
He said that it usually takes 10 to 15 years to make a vaccine and their cost comes from 200 million to 300 million dollars. Since Covid-19 is targeted to develop the vaccine in a year, the expenditure may increase by a hundredfold, from $ 20 billion to $ 30 billion.
Now our effort is to develop the vaccine in one year after reducing it to 10 years. Then we must proceed together on several fronts. It will have to speed up the distribution system from the regulatory level to than the cost may increase to $ 2-3 billion. ‘
India’s vaccine tops the world
Dr. Raghavan said that vaccines prepared in India are of the top class in the world. It is a matter of pride for the country that out of the three vaccines given to children around the world, two are made in India. In the last few years, vaccine companies have not only been manufacturing but are also investing in R&D. Similarly, our startups are also making a big contribution in this field. Apart from these, Individual academics are also doing this work.
These four ways make the vaccine
The country’s Chief Scientific Advisor also gave information about four ways of making vaccines at the press conference. He said, ‘The first approach is the mRNA vaccine. In this, they take the genetic material of the virus and inject it. Our body translocates it into viral proteins. Then the immune response is prepared when the virus enters the body. The second approach is the standard vaccine. They take a weak version of the virus. The Rotavac vaccine we had here was made from the Rotavac strain. It is also being tried for Covid-19. The third method is to create a vaccine by applying the protein-coding region of the virus to the backbone of another virus. In a fourth way, the proteins of the virus are made in the lab and applied with other stimulus. Dr. Raghavan said that the process of preparing the vaccine is going on worldwide through these four methods.
Big role of science and technology
At the same time, Dr. VK Paul, member of NITI Aayog and chairman of Empowered Group-1, formed on Covid-19, said that science and technology have an important role in the fight against Covid-19 and it is heartening that science in our country And the scope of technology is huge.
All the institutions of the country are united
He said, ‘ICMR, Department of Bio-Technology, IIT, Indian Institutes of Science, NIPPERS, ISERS, AIIMS, PJI, CSIR Institutions, DST Institutions, DRDO Institutions, Agriculture Institutions, Space, Atomic Energy, despite limited resources by this country Have created so much. Happily, all these mechanisms are working in the fight against Covid-19. Our institutions and industry have stood together. ‘
Pharmacy of the world is India’s pharma industry
Dr. Paul said that India’s pharma industry is called the Pharmacy of the World. Medicines manufactured in our country go all over the world. He said that Prime Minister Narendra Modi had called upon the youth, scientists, industries, start-ups, etc. of the country to all come forward in finding the vaccine for Covid-19. Dr. Paul said that on the appeal of PM, we are engaged in making new inventions while doing R&D.